The top five states seeing the most substantial increases in COVID-19 ED cases at this time are Nebraska, Idaho, Georgia, Louisiana, and West Virginia.
As of June 25, cases were up across 44 states total, The Washington Post reported.
Per the CDC’s most recent data, KP.3, KP.2, LB.1, and KP.1.1, are the top four subvariants of the JN lineage of the virus that are currently infecting individuals across the U.S. The FDA has already advised vaccine makers to develop their 2024-2025 COVID-19 seasonal booster shots using the KP.2 strain due to increased circulation from it and other variants borne from it.
Twenty-one states where COVID-19 ED visits increased most for the week ending June 22:
- Nebraska: 82.1%
- Percentage of ED visits diagnosed with COVID: 0.3%
- Georgia: 57.3%
- Percentage of ED visits diagnosed with COVID: 0.4%
- Idaho: 56.6%
- Percentage of ED visits diagnosed with COVID: 0.8%
- Louisiana: 39.4%
- Percentage of ED visits diagnosed with COVID: 0.8%
- West Virginia: 34.9%
- Percentage of ED visits diagnosed with COVID: 0.5%
- Virginia: 34.8%
- Florida: 34.7%
- Wisconsin: 33.4%
- Indiana: 30.9%
- Delaware: 29.6%
- Texas: 29.3%
- Pennsylvania: 27.5%
- New Hampshire: 26.6%
- Maryland: 26.6%
- Colorado: 26.3%
- New York: 24.8%
- Ohio: 24.6%
- Iowa: 24.5%
- Nevada: 23.9%
- Massachusetts: 22.8%
- California: 21.7%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
